| Year |
Citation |
Score |
| 2018 |
Huang C, Cao Z, Ma J, Shen Y, Bu Y, Khoshaba R, Shi G, Huang D, Liao DF, Ji H, Jin J, Cao D. AKR1B10 Activates Diacylglycerol (DAG) Second Messenger in Breast Cancer Cells. Molecular Carcinogenesis. PMID 29846015 DOI: 10.1002/Mc.22844 |
0.555 |
|
| 2017 |
Cao Y, Lin M, Bu Y, Ling H, He Y, Huang C, Shen Y, Song B, Cao D. p53-inducible long non-coding RNA PICART1 mediates cancer cell proliferation and migration. International Journal of Oncology. PMID 28339031 DOI: 10.3892/Ijo.2017.3918 |
0.552 |
|
| 2016 |
Bu Y, Cai G, Shen Y, Huang C, Zeng X, Cao Y, Cai C, Wang Y, Huang D, Liao DF, Cao D. Targeting NF-κB RelA/p65 Phosphorylation Overcomes RITA Resistance. Cancer Letters. PMID 27721021 DOI: 10.1016/J.Canlet.2016.10.006 |
0.52 |
|
| 2016 |
Huang C, Verhulst S, Shen Y, Bu Y, Cao Y, He Y, Wang Y, Huang D, Cai C, Rao K, Liao DF, Jin J, Cao D. AKR1B10 promotes breast cancer metastasis through integrin α5/δ-catenin mediated FAK/Src/Rac1 signaling pathway. Oncotarget. PMID 27248472 DOI: 10.18632/Oncotarget.9672 |
0.539 |
|
| 2015 |
Bu Y, Li X, He Y, Huang C, Shen Y, Cao Y, Huang D, Cai C, Wang Y, Wang Z, Liao DF, Cao D. A phosphomimetic mutant of RelA/p65 at Ser536 induces apoptosis and senescence: An implication for tumor-suppressive role of Ser536 phosphorylation. International Journal of Cancer. Journal International Du Cancer. PMID 26375985 DOI: 10.1002/Ijc.29852 |
0.534 |
|
| 2015 |
Shen Y, Ma J, Yan R, Ling H, Li X, Yang W, Gao J, Huang C, Bu Y, Cao Y, He Y, Wan L, Zu X, Liu J, Huang MC, et al. Impaired self-renewal and increased colitis and dysplastic lesions in colonic mucosa of AKR1B8-deficient mice. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1466-76. PMID 25538260 DOI: 10.1158/1078-0432.Ccr-14-2072 |
0.462 |
|
| 2014 |
Wang C, Xu CX, Bu Y, Bottum KM, Tischkau SA. Beta-naphthoflavone (DB06732) mediates estrogen receptor-positive breast cancer cell cycle arrest through AhR-dependent regulation of PI3K/AKT and MAPK/ERK signaling. Carcinogenesis. 35: 703-13. PMID 24163404 DOI: 10.1093/carcin/bgt356 |
0.356 |
|
| 2013 |
Luo D, Bu Y, Ma J, Rajput S, He Y, Cai G, Liao DF, Cao D. Heat shock protein 90-α mediates aldo-keto reductase 1B10 (AKR1B10) protein secretion through secretory lysosomes. The Journal of Biological Chemistry. 288: 36733-40. PMID 24217247 DOI: 10.1074/Jbc.M113.514877 |
0.461 |
|
| 2012 |
Lin J, Jin X, Bu Y, Cao D, Zhang N, Li S, Sun Q, Tan C, Gao C, Jiang Y. Efficient synthesis of RITA and its analogues: derivation of analogues with improved antiproliferative activity via modulation of p53/miR-34a pathway. Organic & Biomolecular Chemistry. 10: 9734-46. PMID 23151607 DOI: 10.1039/C2Ob26627J |
0.48 |
|
| 2012 |
Ma J, Luo DX, Huang C, Shen Y, Bu Y, Markwell S, Gao J, Liu J, Zu X, Cao Z, Gao Z, Lu F, Liao DF, Cao D. AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker. International Journal of Cancer. Journal International Du Cancer. 131: E862-71. PMID 22539036 DOI: 10.1002/Ijc.27618 |
0.528 |
|
| 2012 |
Liu Z, Yan R, Al-Salman A, Shen Y, Bu Y, Ma J, Luo DX, Huang C, Jiang Y, Wilber A, Mo YY, Huang MC, Zhao Y, Cao D. Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells. The Biochemical Journal. 442: 273-82. PMID 22329800 DOI: 10.1042/Bj20111322 |
0.475 |
|
| 2012 |
Bu Y, Cao D. The origin of cancer stem cells. Frontiers in Bioscience (Scholar Edition). 4: 819-30. PMID 22202093 |
0.502 |
|
| Show low-probability matches. |